申请人:YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD.
公开号:EP0359547A1
公开(公告)日:1990-03-21
A novel pyridine compound of the formula
wherein R¹ and R² are the same or different and respectively mean hydrogen, a halogen, an alkyl, an alkoxy or an optionally substituted phenyl; Ar means an optionally substituted aryl or heteroaryl; Y means a single bond or an alkylene which may have double bond(s) in the chain; W means a group of the formula
(wherein R³ and R⁴ are the same or different and respectively mean hydrogen, a halogen, an alkyl, an alkoxy or an optionally substituted phenyl, X means -O-, -S- or -N(R⁵)- (wherein R⁵ means hydrogen, an alkyl or an acyl), Z means a single bond, -O-, -S-, -N(R⁶)- (wherein R⁶ means hydrogen, an alkyl or an acyl) or -CON(R⁷)- (wherein R⁷ means hydrogen, an alkyl or an acyl), A means an alkylene, B means an alkoxycarbonyl, carboxyl, hydroxyl group, -N(R⁸)(R⁹) (wherein R⁸ and R⁹ are the same or different and respectively mean hydrogen, an alkyl, a hydroxyalkyl, an acyl or an optionally substituted aralkyl or heteroaralkyl or conbinedly means a group forming, taken together with the adjacent nitrogen, a heterocyclic group) or -CON(R¹⁰)(R¹¹) (wherein R¹⁰ and R¹¹ are the same or different and respectively mean hydrogen, an alkyl, a hydroxyalkyl, an acyl or an optionally substituted aralkyl or heteroaralkyl, or combinedly mean a group forming, taken together with the adjacent nitrogen, a heterocyclic group), a group of the formula
(wherein R¹² and R¹³ are the same or different and respectively mean hydrogen, an alkyl, a hydroxyalkyl, an acyl, an optionally substituted phenyl or an optionally substituted aralkyl or heteroaralkyl, or combinedly mean a group forming, taken together with the adjacent nitrogen atom, a heterocyclic group, P means -O-, -S(O)p- (wherein p means an integer of 0 to 2), -N(R¹⁴)- (wherein R¹⁴ means hydrogen, an alkyl or an acyl) or -N(R¹⁵)CO- (wherein R¹⁵ means hydrogen, an alkyl or an acyl), Q means an alkylene having not less than 5 carbon atoms, a cyclic alkylene, an alkylene having not less than 4 carbon atoms which has an interposing oxygen or a sulfur therein or an alkylene having not less than 5 carbon atoms which has carbonyl group at the terminus, with the proviso that Q means an alkylene having not less than 3 carbon atoms, when P is -N(R¹⁵)CO-) or a group of the formula
(wherein n means an integer of 3 to 5), or a salt thereof.
The compounds exhibit inhibitory activity on prolylendopeptidase. Also disclosed are pharmaceutical compositions containing the novel pyridine compounds.
一种新型
吡啶化合物,其式如下
其中 R¹ 和 R² 相同或不同,分别表示氢、卤素、烷基、烷氧基或任选取代的苯基;Ar 表示任选取代的芳基或杂芳基;Y 表示单键或链中可能有双键的亚烷基;W 表示式中的基团
(其中 R³ 和 R⁴ 相同或不同,分别指氢、卤素、烷基、烷氧基或任选取代的苯基;X 指 -O-、-S- 或 -N(R⁵)-(其中 R⁵ 指氢、烷基或酰基);Z 指单键、-O-、-S-、-N(R⁶)-(其中 R⁶ 指氢、烷基或酰基)或-CON(R⁷)-(其中 R⁷ 指氢、烷基或酰基),A 指亚烷基、B 表示烷氧基羰基、羧基、羟基、-N(R⁸)(R⁹)(其中 R⁸ 和 R𠞙 相同或不同,分别表示氢、烷基、羟基烷基或酰基)、烷基、羟基烷基、酰基或任选取代的芳烷基或杂烷基,或结合指与邻近的氮一起形成杂环基的基团)或 -CON(R¹⁰)(R¹¹)(其中 R¹⁰ 和 R¹¹ 相同或不同,分别表示氢、烷基、羟基烷基、酰基或任选取代的芳烷基或杂烷基,或与相邻的氮结合形成杂环基的基团),式中的基团
(其中 R¹² 和 R¹³ 相同或不同,分别指氢、烷基、羟基烷基、酰基、任选取代的苯基或任选取代的芳基或杂烷基,或合并指一个基团、P指-O-、-S(O)p-(其中 p 指 0 至 2 的整数)、-N(R¹⁴)-(其中 R¹⁴ 指氢、烷基或酰基)或-N(R¹⁵)CO-(其中 R¹⁵ 指氢、其中 R¹⁵ 指氢、烷基或酰基),Q 指具有不少于 5 个碳原子的亚烷基、环状亚烷基、具有不少于 4 个碳原子的亚烷基(其中有一个中间氧或一个
硫)或具有不少于 5 个碳原子的亚烷基(其末端有羰基),但条件是当 P 为-N(R¹⁵)CO- 时,Q 指具有不少于 3 个碳原子的亚烷基)或式中的基团(其中 n 指整数)。
(其中 n 指 3 至 5 的整数)或其盐。
这些化合物对原内酯肽酶具有抑制活性。还公开了含有新型
吡啶化合物的药物组合物。